PTP8

General Information


DRACP ID  DRACP00105

Peptide Name   PTP8

Sequence  FLKLLAGLLKNFA

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Induce apoptosis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma IC50=24.58 ± 3.24 µg/ml MTT assay 96 h 1
PC-3 Prostate carcinoma Carcinoma IC50=28.90 ± 5.19 µg/ml MTT assay 96 h 1
Hep 3B Childhood hepatocellular carcinoma; Pediatric hepatocellular carcinoma Carcinoma IC50=30.79 ± 3.11 µg/ml MTT assay 96 h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=32.23 ± 9.12 µg/ml MTT assay 96 h 1

Hemolytic Activity  Human RBCs: less than 6% hemolysis at 100 μg/ml

Normal (non-cancerous) Cytotoxicity  HEK293: IC50=26.80 ± 5.52 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00105

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C72H118N16O15

Absent amino acids  CDEHIMPQRSTVWY

Common amino acids  L

Mass  166207

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  9

Net charge  2

Boman Index  1738

Hydrophobicity  126.92

Aliphatic Index  165.38

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 14499271

Title  In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines

Doi 10.1016/s0196-9781(03)00194-3

Year  2003

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  1008

CancerPPD ID  1016

CancerPPD ID  1024

CancerPPD ID  1032

CancerPPD ID  1040

DRACP is developed by Dr.Zheng's team.